Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
BIA 10-2474
Cat. No.:
OB0225LY-0434
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
BIA 10-2474 is a selective diacylglycerol lipase inhibitor.
Synonym:
BIA10-2474; 1233855-46-3; 3-(1-(Cyclohexyl(methyl)carbamoyl)-1H-imidazol-4-yl)pyridine 1-oxide; 1H-Imidazole-1-carboxamide, N-cyclohexyl-N-methyl-4-(1-oxido-3-pyridinyl)-; N-Cyclohexyl-N-methyl-4-(1-oxidopyridin-1-ium-3-yl)imidazole-1-carboxamide
CAS No.:
1233855-46-3
Compound CID:
46831476
Formula:
C16H20N4O2
Formula Weight:
300.36
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
BIA 10-2474 can be used in studies of neuroprotective mechanisms or play an important role in models of neurodegenerative diseases.
Library Information
Targets:
Metabolic enzymes
Receptors:
FAAH
Pathways:
Neuronal signaling; Metabolism; Autophagy
Plate Number:
AOCL-6
Plate Location:
e11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
4 mg/mL; 13.3 mM
ALogP:
1.719
HBA_Count:
2
HBD_Count:
0
Rotatable Bond:
2
